热门资讯> 正文
Dogwood Therapeutics重新遵守纳斯达克最低出价规则
2024-10-30 21:22
- Dogwood Therapeutics (NASDAQ:DWTX), formerly known as Virios Therapeutics, has regained compliance with Nasdaq's minimum bid price requirement.
- DWTX shares were trading +0.90% Wednesday pre-market.
- The biopharmaceutical company said the listing compliance matter is now closed.
- Source: Press Release
More on Virios Therapeutics
- Virios, and Wex Pharmaceuticals report business combination to form Dogwood Therapeutics
- Seeking Alpha’s Quant Rating on Virios Therapeutics
- Historical earnings data for Virios Therapeutics
- Financial information for Virios Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
